Drug intelligence / Profile preview

gallein

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intraperitoneal
01

Overview

Gallein is a synthetic small-molecule xanthene dye (pyrogallol phthalein) that functions as a high-affinity inhibitor of G protein βγ (Gβγ) subunit–dependent signaling, disrupting the interaction of Gβγ with downstream effectors such as phosphoinositide 3-kinase γ (PI3Kγ) and thereby blocking PI3K and Rac1 activation, neutrophil chemotaxis, and related inflammatory responses.[1][2][3][5][7][8][10] Originally developed and used as a biological stain, acid–base indicator, and mordant dye, it has since been widely repurposed as a research tool compound in GPCR/G protein signaling, oncology, immunology, and cardiovascular models, where it demonstrates anticancer, anti-inflammatory, and cardioprotective activities in preclinical systems but is not an approved therapeutic drug.[1][2][3][5][7][8][10]

Other names
Pyrogallol phthaleinPyrogallolphthaleinPyrogallol phthalein indicatorMordant violet 25Alizarin violetAlizarin violet 3RCI 45445CI45445CI-45445Gβγ Modulator II4,5-dihydroxyfluorescein3',4',5',6'-tetrahydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one
02

Targets

Gβγ (G protein beta-gamma subunit complex)

Beyond the preview

Go deeper on gallein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gallein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call